Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Advanced search

Search projects and results

Results 1 - 10 of 21
Results/page:
12 3 > 
Post-genomic datamining of enzymes for the synthesis of chiral pharmaceutical intermediates
ID: 503017
Start date: 2003-12-01, End date: 2006-11-30
Chirality is a key factor in the efficacy of many drugs and the production of single enantiomers of chiral intermediates has therefore become increasingly important. Biocatalysis offers high enantioselectivity and regioselectivity in chiral synthesis through enzyme-catalyzed r...
Programme: FP6-LIFESCIHEALTH
Record Number: 75267
Last updated on: 2009-12-23
Cancer control using populationbased registries and biobanks
ID: 503465
Start date: 2004-06-01, End date: 2009-05-31
Longitudinal studies nested in biobanks enable more reliable and efficient study designs for molecular epidemiology studies, both for design and evaluation of cancer treatment and cancer prevention as well as for exploring and evaluating etiologic hypotheses. However, several ...
Programme: FP6-LIFESCIHEALTH
Record Number: 90043
Last updated on: 2013-03-26
Final Report Summary - DATAGENOM (Post-genomic datamining of enzymes for the synthesis of chiral pharmaceutical intermediates)
The key focus of the DATAGENOM project was on exploiting the recent explosive growth of genomic data that has been made available from the massive Deoxyribonucleic acid (DNA) sequencing programmes. As large-scale DNA sequencing of various life forms has become easier and less ...
Programme: FP6-LIFESCIHEALTH
Record Number: 51605
Last updated on: 2011-04-14
Genomics, mechanisms and treatment of addiction
ID: 5166
Start date: 2005-01-01, End date: 2010-06-30
Addiction is a brain disease, common in Europe, with deleterious consequences on individual physical and psychological health, and serious societal and economic consequences through criminality and violence, decreased productivity and increased healthcare costs. In every famil...
Programme: FP6-LIFESCIHEALTH
Record Number: 74034
Last updated on: 2010-10-07
Molecular mechanisms of resistance, virulence and epidemicity in Streptococcus pneumoniae. PREVIS (Pneumococcal Resistance Epidemicity and Virulence - an international study
ID: 503413
Start date: 2004-01-01, End date: 2007-06-30
Human pathogens face two main kinds of evolutionary challenges. A. Survival and growth in an antibiotic rich milieu selects for genetic traits of resistance. B. Successful drug resistant strains must also be able to compete with other members of the species for colonization, s...
Programme: FP6-LIFESCIHEALTH
Record Number: 78704
Last updated on: 2009-12-23
Final Report Summary - POLYGENE (Inherited risk of breast and prostate cancer)
The overall objective of POLYGENE was to identify inherited risk factors of two important cancers that have been shown to have a substantial genetic component, prostate cancer in men and breast cancer in women. The specific objectives of the project were: 1. Genome-wide ass...
Programme: FP6-LIFESCIHEALTH
Record Number: 47055
Last updated on: 2011-04-14
A large scale genome-wide association study of schizophrenia addressing variation in expressivity and contribution from environmental factors
ID: 37761
Start date: 2006-11-01, End date: 2010-04-30
Schizophrenia (SZ) is a complex and disabling disorder that continues to exact a heavy toll not only upon those afflicted but also on relatives and on our health and welfare systems. Family history significantly increases the risk of developing the disease and evidence from ep...
Programme: FP6-LIFESCIHEALTH
Record Number: 93358
Last updated on: 2013-03-26
Systems biology strategies and metabolome engineering for the enhanced production of recombinant proteins in streptomyces
ID: 37586
Start date: 2007-01-01, End date: 2010-06-30
Streptomyces has been shown to be an invaluable host for the secretory production of biopharmaceuticals and other heterologous proteins. STREPTOMICS aims to further evaluate this host as a cell factory for the industrial production of proteins of diverse origin including from ...
Programme: FP6-LIFESCIHEALTH
Record Number: 86295
Last updated on: 2013-03-26
Inherited risk of breast and prostate cancer
ID: 18827
Start date: 2005-11-01, End date: 2009-08-31
Linkage studies of cancer families have identified high-penetrance cancer genes such as BRCA1 and BRCA2. However, although these genes have resulted in novel insights into cancer, it is clear that a large component of inherited cancer risk remains unacc ounted for. It has been...
Programme: FP6-LIFESCIHEALTH
Record Number: 78403
Last updated on: 2009-12-14
Nowe enzymy do syntezy leków chiralnych
Enzymy bakteryjne stanowią szybkie i selektywne katalizatory reakcji w syntezie leków chiralnych. Wspólne działania europejskich naukowców pozwoliły wykryć i potwierdzić aktywność nowych enzymów biokatalitycznych.
Programme: FP6-LIFESCIHEALTH
Record Number: 89023
Last updated on: 2013-05-20
Available languages: DE, EN, ES, FR, IT, PL
12 3 > 
List retrieved on: 2017-05-26
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top